Brolucizumab
| CAS No. | 1531589-13-5 | Cat. No. | BCP39189 |
| Name | Brolucizumab | ||
| Synonyms | |||
| Formula | C1164H1768N310O372S7 | M. Wt | 26281.17 g·mol−1 |
| Description | Brolucizumab is a humanized single-chain antibody.Brolucizumab was designed to attach to and block a substance called vascular endothelial growth factor A (VEGF-A).VEGF-A is a protein that makes blood vessels grow and leak fluid and blood, damaging the macula. By blocking VEGF-A, brolucizumab reduces the growth of the blood vessels and controls the leakage and swelling. |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.